Cancel
About Andrew Kung
Andrew Kung, MD PhD, is a medical co-founder and Chair of the Department of Pediatrics at Memorial Sloan Kettering, known for his pioneering work in precision genomic medicine in clinical oncology.
Known information
Andrew Kung, MD PhD, holds the position of medical co-founder and serves as the Chair of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center. He is recognized as a key opinion leader (KOL) in the field of clinical oncology, particularly for his early adoption and advocacy of precision genomic medicine approaches. Dr. Kung has made significant contributions to the field, as evidenced by his high h-index of 112, which reflects the impactful nature of his research and publications in oncology.
About Isabl
Isabl, formerly known as Isabl Technologies, is a healthcare diagnostics company spun off from Memorial Sloan Kettering Cancer Center in 2020, headquartered in New York City. The company specializes in genomic diagnostics for cancer, offering comprehensive analysis tools and a remote-first work culture.
Report inaccurate information
